Medicare Enrolled
Dr. Michael Caire, MD
Gastroenterology · Bradenton, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Caire from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Caire?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Caire
Dr. Michael Caire is a gastroenterology specialist in Bradenton, FL, with 16 years of NPI registration. Based on federal Medicare data, Dr. Caire performed 2,055 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Caire received a total of $5,677 from 40 pharmaceutical and/or device companies across 240 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Caire is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ Top 13% volume in FL
$5,677 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,055
Medicare services
Top 13% in FL for gastroenterology
Not available
Unique patients (not deduplicated)
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
910 | $26 | $76 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
250 | $93 | $256 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
189 | $64 | $282 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
150 | $112 | $338 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
115 | $200 | $523 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
108 | $140 | $399 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
99 | $95 | $410 |
| Esophageal dilation with guide wire and endoscope A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage. |
77 | $128 | $339 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
31 | $65 | $227 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
29 | $89 | $206 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
20 | $103 | $273 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
19 | $101 | $268 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
18 | $22 | $58 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
15 | $186 | $379 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
13 | $187 | $380 |
| Limited abdominal ultrasound A focused ultrasound examination of the abdomen to evaluate specific organs or areas. This procedure uses sound waves to create images of internal structures. |
12 | $56 | $176 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
45.2% high complexity
16.8% medium
38.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,677
Total received (2018-2024)
Avg $811/year across 7 years
Top 31% in FL for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
240
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,118
2023
$1,276
2022
$457
2021
$427
2020
$211
2019
$131
2018
$1,057
Payments by company (2024)
ABBVIE INC.
$474
Janssen Biotech, Inc.
$276
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$201
Regeneron Healthcare Solutions, Inc.
$185
QOL Medical, LLC
$172
Takeda Pharmaceuticals U.S.A., Inc.
$125
EVOKE PHARMA, INC.
$118
Lilly USA, LLC
$88
Intercept Pharmaceuticals, Inc.
$81
Madrigal Pharmaceuticals
$80
GENZYME CORPORATION
$58
Phathom Pharmaceuticals, Inc.
$42
Ardelyx, Inc.
$37
Merck Sharp & Dohme LLC
$37
IRONWOOD PHARMACEUTICALS, INC
$27
Celltrion USA Inc.
$24
E.R. Squibb & Sons, L.L.C.
$21
Braintree Laboratories, Inc.
$20
Fresenius Kabi USA, LLC
$19
AIMMUNE THERAPEUTICS, INC.
$17
VIVUS LLC
$15
Top 3 companies account for 45.0% of 2024 payments
All-time payments by company (2018-2024) ›
Covidien LP
$724
ABBVIE INC.
$623
Janssen Biotech, Inc.
$477
AbbVie Inc.
$454
Takeda Pharmaceuticals U.S.A., Inc.
$351
QOL Medical, LLC
$348
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$333
Regeneron Healthcare Solutions, Inc.
$297
Celgene Corporation
$247
GENZYME CORPORATION
$132
Olympus America Inc.
$127
EVOKE PHARMA, INC.
$118
Axonics, Inc.
$106
Ethicon Inc.
$103
Intercept Pharmaceuticals, Inc.
$97
Palette Life Sciences, Inc.
$89
Lilly USA, LLC
$88
Madrigal Pharmaceuticals
$80
RedHill Biopharma Inc.
$79
AbbVie, Inc.
$72
INTERCEPT PHARMACEUTICALS, INC.
$72
Boston Scientific Corporation
$70
BOSTON SCIENTIFIC CORPORATION
$67
Fresenius Kabi USA, LLC
$45
IRONWOOD PHARMACEUTICALS, INC
$43
Phathom Pharmaceuticals, Inc.
$42
Gilead Sciences, Inc.
$41
Braintree Laboratories, Inc.
$40
Ironwood Pharmaceuticals, Inc
$39
Ardelyx, Inc.
$37
Merck Sharp & Dohme LLC
$37
NESTLE HEALTHCARE NUTRITION INC.
$29
Allergan Inc.
$27
Amgen Inc.
$24
Celltrion USA Inc.
$24
Nestle HealthCare Nutrition Inc.
$23
E.R. Squibb & Sons, L.L.C.
$21
Ferring Pharmaceuticals Inc.
$18
AIMMUNE THERAPEUTICS, INC.
$17
VIVUS LLC
$15
Top 3 companies account for 32.1% of all-time payments
Associated products mentioned in payments ›
AVSOLA · Amitiza · Axonics r-SNM System · Barrx · CREON · DIFICID · DUPIXENT · ENTYVIO · EVIS EXERA · EXALT · EXALT BX 2 · EndoArmor · Entyvio · GATTEX · GENERAL POLYPECTOMY · GIMOTI · General - Polypectomy · HUMIRA · Humira · IBSRELA · IDACIO · LINX Reflux Management System · LINZESS · Linzess · MAVYRET · Mavyret · OCALIVA · OMVOH · ORISE · PANCREAZE · REBYOTA · REMICADE · RESMETIROM · RINVOQ · SKYRIZI · SOLESTA · STELARA · SUCRAID · SUFLAVE · SUTAB · Sucraid · TREMFYA · TRULANCE · Talicia · VIBERZI · VOQUEZNA · VOWST · WATCHMAN · XIFAXAN · ZENPEP · ZEPOSIA · ZYMFENTRA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Gastroenterologists in nearby ZIP areas
69
County median income
$75,792
Nearest hospital to ZIP centroid (approximate)
SUNCOAST BEHAVIORAL HEALTH CENTER
4.2 mi
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Caire is a clinical cardiology specialist, with above-average Medicare volume (top 13% in FL), with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Caire experienced with infliximab infusion (remicade)?
Based on Medicare claims data, Dr. Caire performed 910 infliximab infusion (remicade) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Caire receive payments from pharmaceutical companies?
Yes. Dr. Caire received a total of $5,677 from 40 companies across 240 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Caire's costs compare to other gastroenterologists in Bradenton?
Dr. Caire's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Caire) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Bradenton
Browse gastroenterologists in Bradenton ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in FL
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in FL
Which FL gastroenterologists receive the most from drug and device companies.
By company
Covidien LP Payments to Doctors
See all physicians who received payments from Covidien LP.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology